Information Library
Results for: High-quality studies
To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.
- Sort by:
- Recently Added
- Title
-
India Central Laboratory Services
Brochure — February 6, 2012
Quintiles offers a local presence in India alongside seven other wholly owned labs and two affiliates strategically located around the world. Over time, we have developed key relationships in local regulatory and shipping communities, giving us the ability to support investigators in India, elsewhere in Asia or around the globe. -
South Africa Central Laboratory Services
Brochure — February 6, 2012
Quintiles offers a local presence in Africa alongside seven other wholly owned labs and two affiliates strategically located around the world. Over time, we have developed key relationships in local regulatory and shipping communities, giving us the ability to support investigators in Africa or around the globe. -
Quintiles Forms New Biomarker Research and Development Company
Press Release — January 18, 2012 – Quintiles announced that it has invested in a new company formed to provide oncology consulting services and new cancer biomarkers, the key to scientific selection of the right drug for the right patient.
-
The Contribution of Early-phase Clinical Data to a Drug’s Integrated Cardiac Safety Portfolio
Hear from the Experts — January 16, 2012
This article examines the financial and time benefits to incorporating intensive ECG and QT/QTc monitoring in early-phase clinical studies. -
Intarcia and Quintiles Finalize Innovative Alliance
Press Release — December 13, 2011 – To speed development of a potential ground-breaking therapy for Type 2 diabetes – Intarcia Therapeutics, Inc., and Quintiles announced the signing of definitive agreements making Quintiles a financial and strategic partner for the global clinical development of Intarcia’s ITCA 650 (DUROS® continuous subcutaneous delivery of exenatide).
-
Quintiles Launches China CRO, Kun Tuo
Press Release — December 13, 2011 – Further deepening its commitment to China, Quintiles announced the launch of Kun Tuo, a local contract research organization (CRO) built to service the unique needs of the Chinese biopharmaceutical industry and multinational biopharma companies operating in China.
-
The Contribution of Early-phase Clinical Data to a Drug’s Integrated Cardiac Safety Portfolio
Hear from the Experts — December 6, 2011
This article examines the financial and time benefits to incorporating intensive ECG and QT/QTc monitoring in early-phase clinical studies. -
Quintiles Expands World's Largest Cap-Accredited Lab Network
Press Release — December 1, 2011 – Continuing the expansion of its Global Laboratories’ capabilities and resources, Quintiles announced the opening of a new, expanded central lab in Centurion, South Africa.
-
Quintiles and Prodia Partner to Provide Central Lab Testing Solution in Indonesia
Press Release — November 30, 2011 – Quintiles announced an expanded partnership with Jakarta-based Prodia Clinical Laboratory, through its sister company Prodia the CRO, to facilitate rapid testing of samples from patients in clinical trials in Indonesia.
-
Quintiles Named 2011 Frost & Sullivan Asia Pacific CRO of the Year
Press Release — November 29, 2011 – For the fourth time in six years, Quintiles has been named Asia Pacific Contract Research Organization of the Year by Frost & Sullivan.
